Artigo · Revista · 2025

A Phase 1b, Open-label, Multiple-Dose Study Evaluating Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Pociredir in Patients With Sickle Cell Disease (SCD): Trial Design

Sheinei Alan, Johhny Mahlangu, Michael Birrer, Foluke A. Fasola, Blessing Ojika, Livingstone G. Dogara e mais 5

Journal of sickle cell disease.

• Acesso aberto · Dourado
• Com uma empresa
• Internacional · 3 países

Lê-lo10.1093/jscdis/yoaf013.001